A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants

Stopped Sponsor business decision to terminate study. Decision not due to major safety concerns or requests from any regulatory authorities.

Conditions

• Biological Availability
• Healthy Participants

Interventions

• DRUG: Paxlovid
• DRUG: Paxlovid
• DRUG: Nirmatrelvir/ritonavir
• DRUG: Nirmatrelvir/ritonavir

Sponsor

Pfizer